Gries Financial LLC lowered its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 1.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 21,615 shares of the company’s stock after selling 268 shares during the quarter. Gries Financial LLC’s holdings in Colgate-Palmolive were worth $1,965,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. State Street Corp increased its holdings in shares of Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after buying an additional 1,784,411 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Colgate-Palmolive by 2.8% during the 3rd quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company’s stock worth $2,095,325,000 after buying an additional 552,949 shares during the last quarter. Massachusetts Financial Services Co. MA raised its holdings in Colgate-Palmolive by 6.2% in the third quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company’s stock valued at $988,997,000 after buying an additional 557,492 shares during the period. Barclays PLC raised its holdings in Colgate-Palmolive by 38.7% in the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after buying an additional 2,132,747 shares during the period. Finally, FMR LLC raised its holdings in Colgate-Palmolive by 65.6% in the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock valued at $700,642,000 after buying an additional 2,674,807 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Stock Down 0.2 %
Shares of CL stock opened at $89.65 on Thursday. The company has a market capitalization of $73.24 billion, a price-to-earnings ratio of 25.69, a PEG ratio of 3.59 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a twelve month low of $82.68 and a twelve month high of $109.30. The stock’s 50 day simple moving average is $91.67 and its 200 day simple moving average is $97.34.
Colgate-Palmolive Announces Dividend
Analysts Set New Price Targets
CL has been the topic of a number of recent research reports. Stifel Nicolaus reduced their price objective on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research note on Friday, January 17th. Piper Sandler decreased their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. UBS Group decreased their target price on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Finally, Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a report on Wednesday. One research analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive has an average rating of “Hold” and a consensus target price of $102.00.
Get Our Latest Stock Report on CL
Insider Buying and Selling
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.34% of the stock is owned by company insiders.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
- Five stocks we like better than Colgate-Palmolive
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- As China Tightens Rare Earth Exports, These 3 Stocks Are in Focus
- What Are Dividend Challengers?
- Rebuilding the Empire: Can Dollar General Rally in 2025?
- What is a support level?
- Coinbase Gains Momentum on App Store—What It Means for the Stock
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.